NuVasive Specialized Orthopedics reported 10,000 implantations of the Precice® system, used to treat conditions related to limb lengthening and reconstruction. Precice is an Intramedullary nail that employs an External Remote Controller to non-invasively lengthen the limb.
The system obviates the need for external fixation devices or shortening of the healthy limb, both previously considered to be the gold standard of care for patients with limb length discrepancy. Up to 80mm of limb lengthening can be achieved through the patient's use of the remote controller for seven minutes per day.
"With over 10,000 devices implanted and more than 30 peer-reviewed clinical studies published since its commercial release in 2011, Precice has proven to be a validated and preferred approach to addressing limb length discrepancies by surgeons and patients alike," said Massimo Calafiore, president of NuVasive Specialized Orthopedics. "This milestone underscores NuVasive's commitment to innovate with the mission of transforming the current standards of orthopedic care."
NuVasive Specialized Orthopedics reported 10,000 implantations of the Precice® system, used to treat conditions related to limb lengthening and reconstruction. Precice is an Intramedullary nail that employs an External Remote Controller to non-invasively lengthen the limb. The system obviates the need for external fixation...
NuVasive Specialized Orthopedics reported 10,000 implantations of the Precice® system, used to treat conditions related to limb lengthening and reconstruction. Precice is an Intramedullary nail that employs an External Remote Controller to non-invasively lengthen the limb.
The system obviates the need for external fixation devices or shortening of the healthy limb, both previously considered to be the gold standard of care for patients with limb length discrepancy. Up to 80mm of limb lengthening can be achieved through the patient's use of the remote controller for seven minutes per day.
"With over 10,000 devices implanted and more than 30 peer-reviewed clinical studies published since its commercial release in 2011, Precice has proven to be a validated and preferred approach to addressing limb length discrepancies by surgeons and patients alike," said Massimo Calafiore, president of NuVasive Specialized Orthopedics. "This milestone underscores NuVasive's commitment to innovate with the mission of transforming the current standards of orthopedic care."
Copy to clipboard 
